Catalyst Financial Partners LLC Increases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Catalyst Financial Partners LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,852 shares of the medical equipment provider’s stock after acquiring an additional 85 shares during the quarter. Catalyst Financial Partners LLC’s holdings in Intuitive Surgical were worth $910,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Creekmur Asset Management LLC increased its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new position in Intuitive Surgical in the second quarter worth approximately $26,000. Delos Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the last quarter. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical in the 1st quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Raymond James increased their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Citigroup lifted their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Barclays lifted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,095 shares of company stock worth $24,552,712. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 0.5 %

Intuitive Surgical stock opened at $513.77 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $260.17 and a 52-week high of $523.34. The company has a market cap of $182.99 billion, a price-to-earnings ratio of 82.60, a PEG ratio of 5.11 and a beta of 1.39. The firm’s fifty day moving average is $489.74 and its 200 day moving average is $445.30.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.